Drug intelligence / Profile preview

benzydamine + cetylpyridine chloride

Development stage
Unknown
Lead developer
KRKA
Modality
Small Molecules
Administration
Oral (lozenge, Orosoluble Tablet, Mouth Rinse)
01

Overview

Benzydamine + cetylpyridine chloride is a fixed-dose combination drug primarily available as lozenges or orosoluble tablets for the local treatment of sore throat and minor infections of the mouth and throat. Benzydamine is a non-steroidal anti-inflammatory drug (NSAID) with anti-inflammatory, analgesic, local anesthetic, and mild antiseptic properties. Its mechanism is distinct from typical NSAIDs: it inhibits proinflammatory cytokine synthesis (such as TNFα, IL-1β, and MCP-1) and modulates neuronal excitability. Cetylpyridine chloride (CPC) is a cationic quaternary ammonium compound with broad-spectrum antiseptic and antimicrobial action, rapid bactericidal effect on gram-positive bacteria, and fungicidal effect on yeasts. The combination provides symptomatic relief in upper respiratory tract infections, reducing throat pain quickly and for at least several hours after administration. It is indicated for relief of throat pain, gingivitis, stomatitis, and prevention/treatment of local oropharyngeal infections.

Brand names
SeptabeneBenz-C
Other names
benzydamine hydrochloride + cetylpyridinium chlorideCPC/BHCPC + BHcetylpyridinium chloride + benzydamine hydrochloride
02

Targets

Gtf (Streptococcus mutans glucosyltransferase)NaV (Voltage-gated sodium channels)

Beyond the preview

Go deeper on benzydamine + cetylpyridine chloride.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on benzydamine + cetylpyridine chloride.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call